ARKK vs. ARKG

In the year-to-date period, ARKK achieves a -9.55% return, which is significantly higher than ARKG's -10.26% return. Over the past 10 years, ARKK has outperformed ARKG with an annualized return of 10.54%, while ARKG has yielded a comparatively lower 0.04% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Both ARKK and ARKG have an expense ratio of 0.75%.

This table presents a comparison of risk-adjusted performance metrics for ARK Innovation ETF (ARKK) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ARKK Sharpe Ratio is 0.37, which is higher than the ARKG Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of ARKK and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ARKK nor ARKG has paid dividends to shareholders.

The maximum ARKK drawdown since its inception was -80.91%, roughly equal to the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for ARKK and ARKG. For additional features, visit the drawdowns tool.

The current volatility for ARK Innovation ETF (ARKK) is 12.51%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 16.69%. This indicates that ARKK experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.